CSPC Pharma (01093) spent HK $29.8096 million to repurchase 6.44 million shares on September 17th.

17/09/2024

Shiyao Group (01093) announced that the company spent HK$2980.96 million on September 17, 2024...

CSPC PHARMA (01093) announced that the company repurchased 6.44 million shares for a total of 29.8096 million Hong Kong dollars on September 17, 2024, with a buyback price of 4.58-4.66 Hong Kong dollars per share.

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.